 | • レポートコード：PMR21SE008 • 出版社/出版日：Persistence Market Research / 2021年7月9日 • レポート形態：英文、PDF、224ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、再生医療の世界市場について調査し、エグゼクティブサマリー、仮定、調査手法、市場概要、組織別（同種移植、異種移植、異形成）分析、用途別（軟部組織修復、心血管、歯科、整形外科、中枢神経系疾患治療、その他）分析、エンドユーザー別（病院、ASC、教育機関）分析、地域別分析、競争分析、企業情報などを掲載しています。 ・エグゼクティブサマリー ・仮定 ・調査手法 ・市場概要 ・再生医療の世界市場規模：組織別（同種移植、異種移植、異形成） ・再生医療の世界市場規模：用途別（軟部組織修復、心血管、歯科、整形外科、中枢神経系疾患治療、その他） ・再生医療の世界市場規模：エンドユーザー別（病院、ASC、教育機関） ・再生医療の世界市場規模：地域別 ・競争分析 ・企業情報 |
Regenerative Therapies Market: Report Scope
This Persistence Market Research report examines the regenerative therapies market for the period 2021 – 2031. The primary objective of the report is to offer insights into developments in the regenerative therapies market that are significantly helping transform the growth trajectory of global businesses and enterprises associated with the same.
Regenerative therapies entail the application of specific types of cells or cell products for diseased tissues or organs, which ultimately help restore usual tissue and organ function. It also includes the possibility of growing tissues and organs in the laboratory and safely implanting them when the body cannot heal itself.
The regenerative therapies market holds major potential in the near future, which is attributed to the increasing application of these therapies in the treatment of various classes of diseases. The prime factor responsible for the same is the collaborative R&D efforts undertaken by researchers and manufacturers to develop and introduce newer and more efficient therapies.
Orthopedic, cardiovascular, and soft tissue repair are the three main application segments in the global regenerative therapies market. Recently, there has been an alarming rise in the incidence rate of these disorders across the globe. Soft tissue repair and skin restoration therapies are currently the most widely adopted regenerative therapies globally.
Surge in government support and funding from various organizations for R&D related to regenerative therapies over the last few years and increasing incidences of chronic diseases are among the major factors driving growth of the global regenerative therapies market currently.
The regenerative therapies market is segmented as:
Tissue Type
Application
End User
Region
This report covers the global regenerative therapies market performance in terms of revenue contribution from various segments. This section also includes Persistence Market Research’s analysis of the key trends, drivers, restraints and opportunities, which are influencing growth of the global regenerative therapies market currently.
Impact analysis of the key growth drivers and restraints is also included in this report to better equip clients with crystal clear decision-making insights.
The regenerative therapies market report begins with an overview of the regenerative therapies procedures, covering the reasons why the patients are increasingly adopting these therapies. This section also underlines factors influencing growth of the regenerative therapies market currently, along with detailed analysis of the key trends, drivers, restraints, opportunities and regulations.
Impact analysis of the key regional growth drivers and restraints based on the weighted average model, coupled with key region-specific trends, is included in report to better equip clients with information and hidden insights.
The global regenerative therapies market is segmented based on tissue type into allografts, xenografts, and alloplasts. Based on application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopedic, CNS disease treatment, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes.
A detailed analysis of every segment has been presented in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. Among the various tissue types, allografts are expected to emerge as the product of choice both among surgeons and patients worldwide. Xenografts are also expected to gain popularity over the forecast period.
The next section of the report highlights the growth trends in the regenerative therapies market, by region. It provides the market outlook for 2021–2031 and sets the forecast within the context of the regenerative therapies market. The study discusses the key regional trends contributing to growth of the regenerative therapies market worldwide, as well as analyses the extent to which drivers are influencing this market in each region.
Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and the MEA. North America is expected to emerge as the most dominant and most attractive market over the forecast period.
The above sections – by tissue type, by application, by end user, and by region – evaluate the present scenario and growth prospects of the regenerative therapies market for the period 2021 – 2031. We have considered 2020 as the base year and provided data for the forecast period.
Detailed company profiles include company-specific long-term and short-term strategies, key offerings, and recent developments by the concerned companies in the regenerative therapies market.
レポート目次Table of Content
1. Global Regenerative Therapies Market – Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Global Regenerative Therapies Market Overview
4.1. Introduction
4.1.1. Regenerative Therapies Market Definition
4.1.2. Regenerative Therapies Market Taxonomy
4.2. Regenerative Therapies Market Application Overview
4.3. Parent Market Overview
4.4. Regenerative Therapies Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.4.4. Value Chain
4.5. Global Regenerative Therapies Market Forecast, 2021-2031
4.5.1. Market Value Forecast
4.5.2. Y-o-Y Growth Projections
4.5.3. Absolute $ Opportunity
4.6. Regenerative Therapies Market Trends
4.7. Global Regenerative Therapies Market Snapshot (2021)
4.7.1. Market Share, By Application
4.7.2. Market Share, By End User
4.7.3. Market Share, By Product
4.7.4. Market Share, By Region
5. Global Regenerative Therapies Market Analysis, By Tissue Type
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Tissue Type
5.1.2. Market Share & Basis Point (BPS) Analysis, By Tissue Type
5.2. Market Forecast, By Tissue Type
5.2.1. Allograft
5.2.1.1. Absolute $ Opportunity
5.2.1.2. Market Value Forecast, By Region
5.2.2. Xenograft
5.2.2.1. Absolute $ Opportunity
5.2.2.2. Market Value Forecast, By Region
5.2.3. Alloplast
5.2.3.1. Absolute $ Opportunity
5.2.3.2. Market Value Forecast, By Region
5.3. Market Attractiveness Analysis, By Tissue Type
5.4. Prominent Trends
6. Global Regenerative Therapies Market Analysis, By Application
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Application
6.1.2. Market Share & Basis Point (BPS) Analysis, By Application
6.2. Market Forecast, By Application
6.2.1. Soft Tissue Repair
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value Forecast, By Region
6.2.2. Cardiovascular
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value Forecast, By Region
6.2.3. Dental
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value Forecast, By Region
6.2.4. Orthopedic
6.2.4.1. Absolute $ Opportunity
6.2.4.2. Market Value Forecast, By Region
6.2.5. CNS disease treatment
6.2.5.1. Absolute $ Opportunity
6.2.5.2. Market Value Forecast, By Region
6.2.6. Others
6.2.6.1. Absolute $ Opportunity
6.2.6.2. Market Value Forecast, By Region
6.3. Market Attractiveness Analysis, By Application
6.4. Prominent Trends
7. Global Regenerative Therapies Market Analysis, By End User
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By End User
7.1.2. Market Share & Basis Point (BPS) Analysis, By End User
7.2. Market Forecast, By End User
7.2.1. Hospitals
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value Forecast, By Region
7.2.2. Ambulatory Surgical Centers
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value Forecast, By Region
7.2.3. Educational Institutes
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value Forecast, By Region
7.3. Market Attractiveness Analysis, By End User
7.4. Prominent Trends
8. Global Regenerative Therapies Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value Forecast
8.2.2. Latin America Market Value Forecast
8.2.3. Europe Market Value Forecast
8.2.4. Asia Pacific Market Value Forecast
8.2.5. MEA Market Value Forecast
8.3. Regional Attractiveness Analysis
9. North America Regenerative Therapies Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Projections, By Country
9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
9.1.3. Key Regulations
9.1.4. Key Trends
9.2. North America Market Forecast
9.2.1. Market Value Forecast, By Country
9.2.1.1. US Absolute $ Opportunity
9.2.1.2. Canada Absolute $ Opportunity
9.3. Market Value Forecast, By Tissue Type
9.3.1. Allograft
9.3.2. Xenograft
9.3.3. Alloplast
9.4. Market Value Forecast, By Application
9.4.1. Soft Tissue Repair
9.4.2. Cardiovascular
9.4.3. Dental
9.4.4. Orthopedic
9.4.5. CNS disease treatment
9.4.6. Others
9.5. Market Value Forecast, By End User
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Educational Institutes
9.6. Market Attractiveness Analysis
9.6.1. By Country
9.6.2. By Tissue Type
9.6.3. By Application
9.6.4. By End User
9.7. Drivers & Restraints: Impact Analysis
10.1. Introduction
10.1.1. Y-o-Y Growth Projections, By Country
10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
10.1.3. Key Regulations
10.1.4. Key Trends
10.2. Latin America Market Forecast
10.2.1. Market Value Forecast, By Country
10.2.1.1. Brazil Absolute $ Opportunity
10.2.1.2. Mexico Absolute $ Opportunity
10.2.1.3. Rest of Latin America Absolute $ Opportunity
10.3. Market Value Forecast, By Tissue Type
10.3.1. Allograft
10.3.2. Xenograft
10.3.3. Alloplast
10.4. Market Value Forecast, By Application
10.4.1. Soft Tissue Repair
10.4.2. Cardiovascular
10.4.3. Dental
10.4.4. Orthopedic
10.4.5. CNS disease treatment
10.4.6. Others
10.5. Market Value Forecast, By End User
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Educational Institutes
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Tissue Type
10.6.3. By Application
10.6.4. By End User
10.7. Drivers & Restraints: Impact Analysis
11. Europe Regenerative Therapies Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Projections, By Country / Region
11.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
11.1.3. Key Regulations
11.1.4. Key Trends
11.2. Europe Market Forecast
11.2.1. Market Value Forecast, By Country/Region
11.2.1.1. Germany Absolute $ Opportunity
11.2.1.2. United Kingdom Absolute $ Opportunity
11.2.1.3. France Absolute $ Opportunity
11.2.1.4. Rest of Western Europe Absolute $ Opportunity
11.3. Market Value Forecast, By Tissue Type
11.3.1. Allograft
11.3.2. Xenograft
11.3.3. Alloplast
11.4. Market Value Forecast, By Application
11.4.1. Soft Tissue Repair
11.4.2. Cardiovascular
11.4.3. Dental
11.4.4. Orthopedic
11.4.5. CNS disease treatment
11.4.6. Others
11.5. Market Value Forecast, By End User
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Educational Institutes
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Tissue Type
11.6.3. By Application
11.6.4. By End User
11.7. Drivers & Restraints: Impact Analysis
12. Asia Pacific Regenerative Therapies Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Projections, By Country
12.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
12.1.3. Key Regulations
12.1.4. Key Trends
12.2. Asia Pacific Market Forecast
12.2.1. Market Value Forecast, By Country/Region
12.2.1.1. Greater China Absolute $ Opportunity
12.2.1.2. India Absolute $ Opportunity
12.2.1.3. Japan Absolute $ Opportunity
12.2.1.4. Singapore Absolute $ Opportunity
12.2.1.5. Australia and New Zealand Absolute $ Opportunity
12.2.1.6. Rest of APAC Absolute $ Opportunity
12.3. Market Value Forecast, By Tissue Type
12.3.1. Allograft
12.3.2. Xenograft
12.3.3. Alloplast
12.4. Market Value Forecast, By Application
12.4.1. Soft Tissue Repair
12.4.2. Cardiovascular
12.4.3. Dental
12.4.4. Orthopedic
12.4.5. CNS disease treatment
12.4.6. Others
12.5. Market Value Forecast, By End User
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Educational Institutes
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Tissue Type
12.6.3. By Application
12.6.4. By End User
12.7. Drivers & Restraints: Impact Analysis
13. MEA Regenerative Therapies Market Analysis
13.1. Introduction
13.1.1. Y-o-Y Growth Projections, By Country / Region
13.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
13.1.3. Key Regulations
13.1.4. Key Trends
13.2. MEA Market Forecast
13.2.1. Market Value Forecast, By Country/Region
13.2.1.1. GCC Absolute $ Opportunity
13.2.1.2. South Africa Absolute $ Opportunity
13.2.1.3. Rest of MEA Absolute $ Opportunity
13.3. Market Value Forecast, By Tissue Type
13.3.1. Allograft
13.3.2. Xenograft
13.3.3. Alloplast
13.4. Market Value Forecast, By Application
13.4.1. Soft Tissue Repair
13.4.2. Cardiovascular
13.4.3. Dental
13.4.4. Orthopedic
13.4.5. CNS disease treatment
13.4.6. Others
13.5. Market Value Forecast, By End User
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Educational Institutes
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Tissue Type
13.6.3. By Application
13.6.4. By End User
13.7. Drivers & Restraints: Impact Analysis
14.1. Competition Dashboard
14.2. Company Profiles
14.2.1. Revenue
14.2.2. Products/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Highlights
14.3.1. Shire Pharmaceuticals
14.3.2. Kinetic Concepts, Inc.
14.3.3. Mesoblast Ltd.
14.3.4. Cytomedix Inc.
14.3.5. Advanced Cell Technology, Inc.
14.3.6. Organovo Holdings Inc.
14.3.7. Orgenesis Inc.
14.3.8. Genzyme
14.3.9. Athersys, Inc.
14.3.10.Cytori Therapeutics, Inc.
Table 01: Global Regenerative Therapies Market Value, by Tissue Type, 2017–2031 (US$ Mn)
Table 02: Global Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 03: Global Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)
Table 04: Global Regenerative Therapies Market Value, by Region, 2017–2031 (US$ Mn)
Table 05: North America Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 06: North America Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)
Table 07: Latin America Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 08: Latin America Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)
Table 09: Europe Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 10: Europe Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)
Table 11: APAC Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 12: APAC Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)
Table 13: MEA Regenerative Therapies Market Value, by Application, 2017–2031 (US$ Mn)
Table 14: APAC Regenerative Therapies Market Value, by End User, 2017–2031 (US$ Mn)